Use and Outcomes of Subcutaneous Implantable Cardioverter Defibrillator (ICD) After Trans-venous ICD Extraction: an Analysis of Current Clinical Practice and a Comparison with Trans-venous ICD Reimplantation

Il crescente uso di defibrillatori cardioverter impiantabili dopo espianto transvenosi di ICD richiede una valutazione approfondita. (Heart Rhythm 2018 Oct 23)

30 Ottobre Ott 2018 one month ago
  • Dello Russo A

The subcutaneous implantable cardioverter-defibrillator (S-ICD) does not require the insertion of any leads into the cardiovascular system. This analysis describes current practice concerning S-ICD use after transvenous ICD (TV-ICD) explantation.

A new analysis describes current practice concerning S-ICD use after transvenous ICD (TV-ICD) explantation, studying all the 229 consecutive patients who underwent transvenous extraction of an ICD and subsequent implantation of an S-ICD or a single-chamber TV-ICD at 12 Italian centers from 2011 to 2017.

Results show an increasing use of S-ICD over the years in patients undergoing TV-ICD explantation. An S-ICD is preferably adopted in young patients, mostly in the case of infection. Complication rate was comparable between groups, and decreased when a sub or inter-muscular S-ICD generator position was adopted.


Reference
1. Viani S, Migliore F, Tola G, Pisanò EC, Russo AD, Luzzi G, Sartori P, Piro A, Rordorf R, Forleo GB, Rago A, Segreti L, Bertaglia E, Biffi M, Lovecchio M, Valsecchi S, Diemberger I, Bongiorni MG. Use and Outcomes of Subcutaneous Implantable Cardioverter Defibrillator (ICD) After Trans-venous ICD Extraction: an Analysis of Current Clinical Practice and a Comparison with Trans-venous ICD Reimplantation. Heart Rhythm 2018 Oct 23. pii: S1547-5271(18)31053-1. doi: 10.1016/j.hrthm.2018.10.026. [Epub ahead of print] Go to PubMed